Bronchiectasis Treatment Natural

Natural Bronchiectasis Treatment Available at the Lung Institute Using Cellular Therapy

The Lung Institute is proud to offer cellular therapy as a natural bronchiectasis treatment option. Bronchiectasis is an obstructive lung disease characterized by the widening and scarring of the airways, which thereby creates a blockage of mucus that leads to chronic infection. People living with bronchiectasis often experience coughing and difficulty breathing. Other symptoms include wheezing, fatigue, fever, chills, chest pain and joint pain.

Unfortunately, there is currently no cure for this condition. Nevertheless, many people who are living with bronchiectasis find that certain natural treatment methods help to manage their condition and improve their quality of life. Some of these treatments include chest physiotherapy and breathing exercises.

The Lung Institute offers another way to naturally treat bronchiectasis:  minimally invasive cellular therapy. This alternative treatment method is unique in that it has the potential to actually promote healing within the lungs, as opposed to simply treating the symptoms of the disease. Our cellular therapy involves a three-step process, which is performed on an outpatient basis:

  • Collection — First, we collect a sample of cells from either your blood or your bone marrow.
  • Separation — Next, we separate the cells from the remaining cells in your sample, using our onsite lab.
  • Reintroduction — Finally, we inject the concentrated cells back into your bloodstream. Because we use your own cells, there is no risk of rejection once we reintroduce the cells to your body.

If you would like to learn more about using cellular therapy for the natural treatment of bronchiectasis, please call the Lung Institute today at (800) 729-3065. We are the only clinic in the world that exclusively focuses on using cells to treat lung disease, and we would love the opportunity to help you breathe easier.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.